Skip to content

NBTX - Nanobiotix S.A. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

Nanobiotix

NBTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NBTXNanobiotix

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $57.14
52-wk low: $8.03
Prev close: $33.09
Mkt cap: $2.31B
Fwd P/E: 111.1x
Beta: 0.57

Smart money

4 funds hold a position.

Real smart money

Funds holding this stock

4 holders

Combined position$1.1M

MI
Millennium
Israel Englander · Q4 2025 13F
$390K
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -73.5%
Forward P/E: 111.11
Market cap: $2.3B

Valuation

P/S70.75
P/B65.02

Quality

Operating margin-196.4%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NBTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $2.31B
Beta: 0.57

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

70.8x

P/B

65.0x

Profit margin

-73.5%

Op margin

-196.4%

ROE

-198.7%

$379K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$228K

position

1 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 1 holders

Coverage gaps for NBTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

Reports Sep 29, 2026, in 39 days

ROE

-198.7%

ROA-10.1%

Growth

Beta0.57